Table 1.
THN track analysis statistic values. Values for Control (DMSO) and glycine on > 28 hpf embryos are taken from [3].
| Condition | N (embryos) | N (tracks) | p value (to control) | Chi2 (to control) |
|---|---|---|---|---|
| Control (DMSO) dorsal | 19 | 147 | ||
| Control (DMSO) ventral | 19 | 356 | ||
| Control + Bumetanide dorsal | 12 | 102 | 0.71645 | 0.13192 |
| Control + Bumetanide ventral | 12 | 184 | 0.24062 | 1.37693 |
| Glycine > 28 hpf dorsal | 20 | 72 | 0.21939 | 1.50835 |
| Glycine > 28 hpf ventral | 20 | 609 | 5.7123 × 10−8 | 29.45863 |
| Glycine < 28 hpf dorsal | 15 | 58 | 0.60204 | 0.27193 |
| Glycine < 28 hpf ventral | 15 | 170 | 1.989 × 10−27 | 111.72773 |
| GlyRa1 I67F dorsal | 18 | 34 | 0.48558 | 0.48631 |
| GlyRa1 I67F ventral | 18 | 174 | 1.0835 × 10−4 | 14.9854 |
| GlyRa1 V304M dorsal | 29 | 58 | 0.02543 | 4.9946 |
| GlyRa1 V304M ventral | 29 | 251 | 0.12619 | 2.33878 |
| GlyRa1 V304M + Bumetanide dorsal | 18 | 84 | 0.42238 (to V304M: 0.00926) | 0.64368 (to V304M: 6.77131) |
| GlyRa1 V304M + Bumetanide ventral | 18 | 161 | 0.82367 | 0.04965 |
| GlyRa3 P185L dorsal | 19 | 56 | 0.01567 | 5.83959 |
| GlyRa3 P185L ventral | 19 | 194 | 0.29574 | 1.0933 |